Reporting & Disclosures

ISSB Chair Praises China's Progress on Adoption of Global Standards

06/07/2025

Speaking in Beijing, Emmanuel Faber lauded China's leadership and outlined the next phase of implementation for global rules.

Tokenisation

UK and Singapore Deepen Ties on Digital and Sustainable Finance

06/07/2025

Regulators to deepen collaboration on asset tokenisation and AI, while aligning on sustainable finance disclosures and capital market reforms.

Cloud & Infrastructure

Taiwan FSC Amends FinTech Grant Rules to Enhance Transparency

06/07/2025

The FSC has revised its FinTech grant programme, clarifying ineligible costs and formalising its review process to spur innovation.

Trading & Investment

FX Global Code Gains Traction in Asia, Middle East, GFXC Says

05/07/2025

The GFXC reports growing adherence from emerging markets and is now shifting its focus to increasing adoption among buy-side firms.

PEPs & Sanctions

China Sanctions Former Philippine Senator Over South China Sea Laws

05/07/2025

China has barred Francis Tolentino, author of maritime laws challenging its territorial claims, from entering China, Hong Kong and Macau.

Cloud & Infrastructure

US Lifts Curbs on Chip Design Software Exports to China

05/07/2025

The move provides a reprieve for top electronic design automation firms and signals a thaw in trade tensions following a recent agreement.

Sustainable Finance

Singapore, UK, Kenya Launch Alliance to Bolster Voluntary Carbon Markets

04/07/2025

The government-led alliance aims to restore corporate confidence and unlock climate finance by setting clear, high-integrity standards for voluntary carbon markets.

Supervision & Enforcement

Korean Regulator Flags Sharp Rise in Foreign Exchange Breaches

04/07/2025

The FSS reports a 45% surge in foreign exchange violations, with failures in reporting overseas direct investments leading the breaches.

Structural Regulation

Shanghai STAR Market Approves First Unprofitable IPO Under Revived Rules

04/07/2025

Wuhan-based drugmaker Healthgen Biotechnology got the approval, signalling renewed policy support for innovative, pre-revenue technology and life sciences firms.